SOCIAL QUESTIONS|health|illness
- fiabhras buí Tagairt Faomhadh an téarma seo mar chuid de Thionscadal Lex
- ga
- Comhthéacs 'Ní dhearna Ballstáit tuairisciú ar aon chásanna den phlá, den bholgach nó de GTR (géarshiondróm trom riospráide) in 2009, ach bhí cás amháin den fhiabhras buí (taistealaí chuig Gána).' Tagairt 'Tuarascáil bhliantúil eipidéimeolaíochta 2011,' an Lárionad Eorpach um Ghalair a Chosc agus a Rialú (ECDC), https://ecdc.europa.eu/sites/portal/files/media/ga/publications/Publications/1111_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf [26.3.2019]
- yellow fever
- en
- Sainmhíniú acute viral haemorrhagic disease caused by an arbovirus of the Flavivirus genus and transmitted by infected mosquitoes belonging to the Aedes and Haemogogus genera, especially the Aedes aegypti species (the urban yellow fever vector) Tagairt COM-EN, based on:‘Yellow Fever Fact Sheet’ (Updated May 2016). World Health Organization, http://www.who.int/mediacentre/factsheets/fs100/en/ [23.8.2016]
- Nóta - Symptoms include fever, headache, jaundice, muscle pain, nausea, vomiting and fatigue.- A small proportion of patients who contract the virus develop severe symptoms and approximately half of those die within 7 to 10 days.- The virus is endemic in tropical areas of Africa and Central and South America.- Since the launch of the Yellow Fever Initiative in 2006, significant progress in combating the disease has been made in West Africa and more than 105 million people have been vaccinated in mass campaigns. No outbreaks of yellow fever were reported in West Africa during 2015.- Large epidemics of yellow fever occur when infected people introduce the virus into heavily populated areas with high mosquito density and where most people have little or no immunity, due to lack of vaccination. In these conditions, infected mosquitoes transmit the virus from person to person.- Yellow fever is prevented by an extremely effective vaccine, which is safe and affordable. A single dose of yellow fever vaccine is sufficient to confer sustained immunity and life-long protection against yellow fever disease and a booster dose of the vaccine is not needed. The vaccine provides effective immunity within 30 days for 99% of persons vaccinated.- Good supportive treatment in hospitals improves survival rates. There is currently no specific anti-viral drug for yellow fever.See also: sylvatic (jungle) yellow fever [ IATE:1501028 ]
- fièvre jaune
- fr
- Sainmhíniú La fièvre jaune est une maladie virale due au virus de la fièvre jaune, ou virus amaril, qui appartient au groupe des flavivirus. Le virus est transmis d'un vertébré à l'autre (transmission horizontale) par un moustique piqueur (le vecteur). Plusieurs espèces de moustiques appartenant aux genres Aedes et Haemagogus (ce dernier en Amérique du Sud seulement) transmettent le virus de la fièvre jaune. Tagairt http://www.who.int/mediacentre/factsheets/fs100/fr/index.html (5.4.2006)